Pharmacogenetics of the Human Hydroxycarboxylic Acid Receptor 2 (HCAR2)
Time: 12:00 pm
day: Conference Day Two
Details:
- Synaptic adhesion molecules interface with GPCRs and allosterically modulate their pharmacological properties
- Disruption of these molecules lead to neuropsychiatric and neurodevelopmental consequences in animal models and humans
- Targeting these GPCRs, or the interface between GPCRs and synaptic adhesion molecules, may represent a new direction in pharmacological strategies
